In Vitro Fertilization with Preimplantation Genetic Screening
Sebastiaan Mastenbroek, M.Sc., Moniek Twisk, M.D., Jannie van Echten-Arends, Ph.D., Birgit Sikkema-Raddatz, Ph.D., Johanna C. Korevaar, Ph.D., Harold R. Verhoeve, M.D., Niels E.A. Vogel, M.D., Eus G.J.M. Arts, Ph.D., Jan W.A. de Vries, Ph.D., Patrick M. Bossuyt, Ph.D., Charles H.C.M. Buys, Ph.D., Maas Jan Heineman, M.D., Ph.D., Sjoerd Repping, Ph.D., and Fulco van der Veen, M.D., Ph.D.
Background Pregnancy rates in women of advanced maternal ageundergoing in vitro fertilization (IVF) are disappointinglylow. It has been suggested that the use of preimplantation geneticscreening of cleavage-stage embryos for aneuploidies may improvethe effectiveness of IVF in these women.
Methods We conducted a multicenter, randomized, double-blind,controlled trial comparing three cycles of IVF with and withoutpreimplantation genetic screening in women 35 through 41 yearsof age. The primary outcome measure was ongoing pregnancy at12 weeks of gestation. The secondary outcome measures were biochemicalpregnancy, clinical pregnancy, miscarriage, and live birth.
Results Four hundred eight women (206 assigned to preimplantationgenetic screening and 202 assigned to the control group) underwent836 cycles of IVF (434 cycles with and 402 cycles without preimplantationgenetic screening). The ongoing-pregnancy rate was significantlylower in the women assigned to preimplantation genetic screening(52 of 206 women [25%]) than in those not assigned to preimplantationgenetic screening (74 of 202 women [37%]; rate ratio, 0.69;95% confidence interval [CI], 0.51 to 0.93). The women assignedto preimplantation genetic screening also had a significantlylower live-birth rate (49 of 206 women [24%] vs. 71 of 202 women[35%]; rate ratio, 0.68; 95% CI, 0.50 to 0.92).
Conclusions Preimplantation genetic screening did not increasebut instead significantly reduced the rates of ongoing pregnanciesand live births after IVF in women of advanced maternal age.(Current Controlled Trials number, ISRCTN76355836
[controlled-trials.com]
.)
Source Information
From the Center for Reproductive Medicine (S.M., M.T., J.W.A.V., S.R., F.V.) and the Department of Clinical Epidemiology and Biostatistics (J.C.K., P.M.B.), Academic Medical Center, University of Amsterdam, Amsterdam; the Section of Reproductive Medicine, Department of Obstetrics and Gynecology (M.T., J.E.-A., N.E.A.V., E.G.J.M.A., M.J.H.), and the Department of Genetics (B.S.-R., C.H.C.M.B.), University Medical Center Groningen, University of Groningen, Groningen; and the Department of Obstetrics and Gynecology, Onze Lieve Vrouwe Gasthuis, Amsterdam (H.R.V.) all in the Netherlands.
Address reprint requests to Dr. Repping at the Center for Reproductive Medicine, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, the Netherlands, or at s.repping{at}amc.uva.nl.
Vanneste, E., Voet, T., Melotte, C., Debrock, S., Sermon, K., Staessen, C., Liebaers, I., Fryns, J.-P., D'Hooghe, T., Vermeesch, J. R.
(2009). What next for preimplantation genetic screening? High mitotic chromosome instability rate provides the biological basis for the low success rate. Hum Reprod
24: 2679-2682
[Abstract][Full Text]
Bouffard, C., Viville, S., Knoppers, B. M.
(2009). Genetic diagnosis of embryos: Clear explanation, not rhetoric, is needed. CMAJ
181: 387-391
[Full Text]
Benagiano, G., Carrara, S., Filippi, V.
(2009). Sex and reproduction: an evolving relationship. Hum Reprod Update
0: dmp028v1-dmp028
[Abstract][Full Text]
Rubio, C., Gimenez, C., Fernandez, E., Vendrell, X., Velilla, E., Parriego, M., Rodrigo, L., for Spanish Interest Group in Preimplantation Gene,
(2009). The importance of good practice in preimplantation genetic screening: critical viewpoints. Hum Reprod
24: 2045-2047
[Full Text]
Devroey, P., Fauser, B.C.J.M., Diedrich, K., on behalf of the Evian Annual Reproduction (EVAR),
(2009). Approaches to improve the diagnosis and management of infertility. Hum Reprod Update
15: 391-408
[Abstract][Full Text]
Aarden, E., Van Hoyweghen, I., Vos, R., Horstman, K.
(2009). Providing preimplantation genetic diagnosis in the United Kingdom, The Netherlands and Germany: a comparative in-depth analysis of health-care access. Hum Reprod
24: 1542-1547
[Abstract][Full Text]
Hernandez, E. R.
(2009). What next for preimplantation genetic screening? Beyond aneuploidy. Hum Reprod
24: 1538-1541
[Abstract][Full Text]
Beyer, C.E., Osianlis, T., Boekel, K., Osborne, E., Rombauts, L., Catt, J., Kralevski, V., Aali, B.S., Gras, L.
(2009). Preimplantation genetic screening outcomes are associated with culture conditions. Hum Reprod
24: 1212-1220
[Abstract][Full Text]
Meintjes, M., Chantilis, S. J., Ward, D. C., Douglas, J. D., Rodriguez, A. J., Guerami, A. R., Bookout, D. M., Barnett, B. D., Madden, J. D.
(2009). A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. Hum Reprod
24: 782-789
[Abstract][Full Text]
Desmyttere, S., De Schepper, J., Nekkebroeck, J., De Vos, A., De Rycke, M., Staessen, C., Liebaers, I., Bonduelle, M.
(2009). Two-year auxological and medical outcome of singletons born after embryo biopsy applied in preimplantation genetic diagnosis or preimplantation genetic screening. Hum Reprod
24: 470-476
[Abstract][Full Text]
Yanagimachi, R.
(2009). Germ Cell Research: A Personal Perspective. Biol. Reprod.
80: 204-218
[Abstract][Full Text]
Wells, D., Alfarawati, S., Fragouli, E.
(2008). Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. Mol Hum Reprod
14: 703-710
[Abstract][Full Text]
Twisk, M., Mastenbroek, S., Hoek, A., Heineman, M.-J., van der Veen, F., Bossuyt, P. M., Repping, S., Korevaar, J. C.
(2008). No beneficial effect of preimplantation genetic screening in women of advanced maternal age with a high risk for embryonic aneuploidy. Hum Reprod
23: 2813-2817
[Abstract][Full Text]
Staessen, C., Verpoest, W., Donoso, P., Haentjens, P., Van der Elst, J., Liebaers, I., Devroey, P.
(2008). Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Hum Reprod
23: 2818-2825
[Abstract][Full Text]
Mastenbroek, S., Scriven, P., Twisk, M., Viville, S., Van der Veen, F., Repping, S.
(2008). What next for preimplantation genetic screening? More randomized controlled trials needed?. Hum Reprod
23: 2626-2628
[Abstract][Full Text]
Fauser, B. C.J.M.
(2008). Preimplantation genetic screening: the end of an affair?. Hum Reprod
23: 2622-2625
[Full Text]
Fritz, M. A.
(2008). Perspectives on the efficacy and indications for preimplantation genetic screening: where are we now?. Hum Reprod
23: 2617-2621
[Full Text]
Simpson, J. L.
(2008). What next for preimplantation genetic screening? Randomized clinical trial in assessing PGS: necessary but not sufficient. Hum Reprod
23: 2179-2181
[Abstract][Full Text]
Obradors, A., Fernandez, E., Oliver-Bonet, M., Rius, M., de la Fuente, A., Wells, D., Benet, J., Navarro, J.
(2008). Birth of a healthy boy after a double factor PGD in a couple carrying a genetic disease and at risk for aneuploidy: Case Report. Hum Reprod
23: 1949-1956
[Abstract][Full Text]
Yakin, K., Urman, B.
(2008). What next for preimplantation genetic screening? A clinician's perspective. Hum Reprod
23: 1686-1690
[Abstract][Full Text]
Vergouw, C.G., Botros, L.L., Roos, P., Lens, J.W., Schats, R., Hompes, P.G.A., Burns, D.H., Lambalk, C.B
(2008). Metabolomic profiling by near-infrared spectroscopy as a tool to assess embryo viability: a novel, non-invasive method for embryo selection. Hum Reprod
23: 1499-1504
[Abstract][Full Text]
Jansen, R. P.S., Bowman, M. C., de Boer, K. A., Leigh, D. A., Lieberman, D. B., McArthur, S. J.
(2008). What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Hum Reprod
23: 1476-1478
[Abstract][Full Text]
Zosmer, A., Epstein, M., Al-Shawaf, T.
(2008). Ethical recruitment of patients for PGS trial. Hum Reprod
23: 1472-1472
[Full Text]
Ankum, W. M., Reitsma, J. B., Offringa, M.
(2008). Reply: Ethical recruitment of patients for PGS trial. Hum Reprod
23: 1472-1473
[Full Text]
The ESHRE Capri Workshop Group,
(2008). Genetic aspects of female reproduction. Hum Reprod Update
0: dmn009v1-15
[Abstract][Full Text]
Ogilvie, C. M.
(2008). Preimplantation testing for chromosome aneuploidy. The Obstetrician and Gynaecologist
10: 88-92
[Abstract][Full Text]
Combelles, C. M.H.
(2008). What are the trade-offs between one-cell and two-cell biopsies of preimplantation embryos?. Hum Reprod
23: 493-498
[Full Text]
Weghofer, A., Munne, S., Brannath, W., Chen, S., Tomkin, G., Cekleniak, N., Garrisi, M., Barad, D., Cohen, J., Gleicher, N.
(2008). The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. Hum Reprod
23: 499-503
[Abstract][Full Text]
Harper, J., Sermon, K., Geraedts, J., Vesela, K., Harton, G., Thornhill, A., Pehlivan, T., Fiorentino, F., SenGupta, S., de Die-Smulders, C., Magli, C., Moutou, C., Wilton, L.
(2008). What next for preimplantation genetic screening?. Hum Reprod
23: 478-480
[Abstract][Full Text]
Ankum, W. M., Reitsma, J. B., Offringa, M.
(2008). IVF with preimplantation genetic screening, a promising new treatment with unexpectedly negative health outcomes: the Hippocratic role of Data Monitoring Committees. Hum Reprod
23: 1-3
[Abstract][Full Text]
Munne, S., Cohen, J., Simpson, J. L., Wilton, L. J., Handyside, A. H., Thornhill, A. R., Mastenbroek, S., van der Veen, F., Repping, S.
(2007). In Vitro Fertilization with Preimplantation Genetic Screening. NEJM
357: 1769-1771
[Full Text]
Braude, P., Flinter, F.
(2007). Use and misuse of preimplantation genetic testing. BMJ
335: 752-754
[Full Text]
(2007). Preimplantation Genetic Screening and Pregnancy Outcome. JWatch Women's Health
2007: 1-1
[Full Text]
Collins, J. A.
(2007). Preimplantation Genetic Screening in Older Mothers. NEJM
357: 61-63
[Full Text]